Management indicated that on-ground demand momentum remained healthy in 3QFY26
Year: 2026
The company has revised its guidance for revenue growth to be around Rs 3,000...
As of Dec’25, MAN’s aggregate executable order book stands at ~Rs 4,000 cr, providing...
It continues to gain market share across categories, with particularly strong momentum in BLDC...
Jubilant Pharmova (JPL) is an integrated, multi-dimensional pharmaceuticals company with global presence.
Existing hospitals sustained strong performance, delivering a robust 33% YoY revenue growth
The company has maintained a healthy order book of ₹ 1685 crore (as on...
PGIL’s diversified business model brings in more resilience in the performance with revenues and...
top 15 companies from the NSE 500 basket that provide higher dividend yields
We have updated our Top Picks by replacing Inox Wind with Dalmia Bharat Ltd,...
